GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Dividend Payout Ratio

Taisho Pharmaceutical Holdings Co (TSE:4581) Dividend Payout Ratio : 0.00 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Dividend Payout Ratio?

Taisho Pharmaceutical Holdings Co's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio or its related term are showing as below:

TSE:4581' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.27   Med: 0.36   Max: 0.74
Current: 0.58


During the past 13 years, the highest Dividend Payout Ratio of Taisho Pharmaceutical Holdings Co was 0.74. The lowest was 0.27. And the median was 0.36.

TSE:4581's Dividend Payout Ratio is ranked worse than
75.7% of 428 companies
in the Drug Manufacturers industry
Industry Median: 0.33 vs TSE:4581: 0.58

As of today (2024-04-29), the Dividend Yield % of Taisho Pharmaceutical Holdings Co is 1.17%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Taisho Pharmaceutical Holdings Co was 2.13%. The lowest was 0.79%. And the median was 1.45%.

Taisho Pharmaceutical Holdings Co's Dividends per Share for the months ended in Dec. 2023 was 円0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was -3.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -2.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -1.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Taisho Pharmaceutical Holdings Co was 33.90% per year. The lowest was -5.90% per year. And the median was 0.05% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Taisho Pharmaceutical Holdings Co Dividend Payout Ratio Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Dividend Payout Ratio Chart

Taisho Pharmaceutical Holdings Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.54 0.52 0.74 0.42

Taisho Pharmaceutical Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.94 -

Competitive Comparison of Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio falls into.



Taisho Pharmaceutical Holdings Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2023 )/ EPS without NRI (A: Mar. 2023 )
=100/ 239.971
=0.42

Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ 36.557
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taisho Pharmaceutical Holdings Co (TSE:4581) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Taisho Pharmaceutical Holdings Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Taisho Pharmaceutical Holdings Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Traded in Other Exchanges
Address
3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655
Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines